These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28118262)

  • 1. Permanent Atrial Fibrillation and 2 Year Clinical Outcomes in Patients with a Left Ventricular Assist Device Implant.
    Oezpeker C; Zittermann A; Pühler T; Ensminger S; Gummert JF; Morshuis M
    ASAIO J; 2017; 63(4):419-424. PubMed ID: 28118262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
    Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
    Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and adverse events in patients with atrial fibrillation at left ventricular assist device implantation: an analysis of the European Registry for Patients with Mechanical Circulatory Support.
    Antonides CFJ; Yalcin YC; Veen KM; Muslem R; De By TMMH; Bogers AJJC; Gustafsson F; Caliskan K
    Eur J Cardiothorac Surg; 2022 May; 61(5):1164-1175. PubMed ID: 35076057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy.
    Pedde D; Soltani S; Stein J; Tsyganenko D; Müller M; Schönrath F; Falk V; Potapov EV
    Eur J Cardiothorac Surg; 2020 Feb; 57(2):325-330. PubMed ID: 31317177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative atrial fibrillation may not increase thromboembolic events in left ventricular assist device recipients on midterm follow-up.
    Xia Y; Stern D; Friedmann P; Goldstein D
    J Heart Lung Transplant; 2016 Jul; 35(7):906-12. PubMed ID: 27132796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
    Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Preoperative Atrial Fibrillation on Postoperative Thromboembolic Events After Left Ventricular Assist Device Implantation.
    Xuereb L; Go PH; Kaur B; Akrawe S; Nemeh HW; Borgi J; Williams CT; Paone G; Morgan JA
    Ann Thorac Surg; 2016 Nov; 102(5):1543-1549. PubMed ID: 27469338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device.
    Enriquez AD; Calenda B; Gandhi PU; Nair AP; Anyanwu AC; Pinney SP
    J Am Coll Cardiol; 2014 Nov; 64(18):1883-90. PubMed ID: 25444141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of Preoperative Existence of Atrial Fibrillation on Hemocompatibility-Related Adverse Events During Left Ventricular Assist Device Support.
    Imamura T; Kinugawa K; Ono M; Kinoshita O; Fukushima N; Shiose A; Matsui Y; Yamazaki K; Saiki Y; Usui A; Niinami H; Matsumiya G; Arai H; Sawa Y
    Circ J; 2019 May; 83(6):1286-1292. PubMed ID: 31019163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-Analysis of the Effect of Preoperative Atrial Fibrillation on Outcomes After Left Ventricular Assist Device Implantation.
    Usman MS; Ahmed S; Yamani N; Akhtar T; Asmi N; Siddiqi TJ; Khan SU; Doukky R; Khan MS
    Am J Cardiol; 2019 Jul; 124(1):158-162. PubMed ID: 31047654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Fibrillation Is Not Associated With Thromboembolism in Left Ventricular Assist Device Patients: A Systematic Review and Meta-Analysis.
    Kittipibul V; Rattanawong P; Kewcharoen J; Chongsathidkiet P; Vutthikraivit W; Kanjanahattakij N
    ASAIO J; 2019 Jul; 65(5):456-464. PubMed ID: 29877887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Atrial Fibrillation on In-Hospital Mortality and Thromboembolic Complications after Left Ventricular Assist Device Implantation.
    Blumer V; Ortiz Bezara M; Kittipibul V; Greene SJ; Fudim M; Hernandez GA; Chaparro S; Joyce E
    J Cardiovasc Transl Res; 2021 Feb; 14(1):120-124. PubMed ID: 32076994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis. The Loire Valley Atrial Fibrillation Project.
    Philippart R; Brunet-Bernard A; Clementy N; Bourguignon T; Mirza A; Angoulvant D; Babuty D; Lip GY; Fauchier L
    Thromb Haemost; 2016 May; 115(5):1056-63. PubMed ID: 26843425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is heart rate important for patients with heart failure in atrial fibrillation?
    Cullington D; Goode KM; Zhang J; Cleland JG; Clark AL
    JACC Heart Fail; 2014 Jun; 2(3):213-20. PubMed ID: 24952686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.